×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Dova Pharmaceuticals to be Acquired by Swedish Orphan Biovitrum AB (Sobi)
GlobeNewswire
Consideration of up to $29.00 per share includes $27.50 per share in upfront cash and an additional $1.50 per share upon regulatory approval...
56 months ago
Sobi acquires hematology company Dova Pharmaceuticals
BioStock
Sobi acquires hematology company Dova Pharmaceuticals ... This week specialist drug company Sobi announced that it will acquire Dova...
35 months ago
Sobi snags Dova for $915M, hoping to flesh out its hematology franchise
Fierce Pharma
When drugmakers look to build out certain therapeutic areas, there are two options: Create your own and buy someone else's.
56 months ago
China National Medical Products Administration Approves DOPTELET® (avatrombopag) for the treatment of ...
BioSpace
China National Medical Products Administration Approves DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients...
49 months ago
Dova Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for DOPTELET ...
GlobeNewswire
Company Strengthens Thrombocytopenia Portfolio with ITP Approval and Expanded Partnership with Salix for Chronic Liver Disease (CLD)...
59 months ago
Dova Pharmaceuticals (DOVA) Doptelet FDA Approval Conference Call - Slideshow (NASDAQ:DOVA-DEFUNCT ...
Seeking Alpha
The following slide deck was published by Dova Pharmaceuticals in conjunction with this event.
72 months ago
Dova Pharmaceuticals' CEO is out - Triangle Business Journal
The Business Journals
Dova Pharmaceuticals CEO Alex Sapir is out, and a former United Therapeutics executive is coming to take the reins.
65 months ago
Durham pharma firm Dova merging with Swedish biotech in deal worth up to $915M
WRAL TechWire
Dova Pharmaceuticals is being acquired by a Swedish biotech company in a deal worth as much as $915 million in a deal announced Monday.
56 months ago
Mid-Day Market Update: Crude Oil Down Over 1%; Diffusion Pharmaceuticals Shares Spike Higher - Ameris (NA
Benzinga
Midway through trading Monday, the Dow traded down 0.22 percent to 24,047.50 while the NASDAQ climbed 0.12 percent to 6,918.63.
65 months ago
New IPO Movers of the Week (Aug. 14-18, 2017)
Money Morning
It's mostly new faces on this week's new IPO* movers of the week list, though we do have one repeat winner. Dova Pharmaceuticals Inc.
81 months ago